A Study of ZN-c3 in Subjects With High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at Orange, California and other locations
- Dates
- study startedcompletion around
- Principal Investigator
- by Krishnansu Tewari
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Lead Scientist at UC Irvine
- Krishnansu Tewari
Professor, Obstetrics and Gynecology, School of Medicine. Authored (or co-authored) 233 research publications
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
- ID
- NCT05128825
- Phase
- Phase 2 Peritoneal Cancer Research Study
- Study Type
- Interventional
- Participants
- Expecting 90 study participants
- Last Updated